Close Menu

NEW YORK (GenomeWeb) – Researchers have uncovered a long non-coding RNA that is associated with androgen receptor signaling in prostate cancer progression and might serve as a drug target.

Prostate cancer, which affects nearly 165,000 men a year in the US, is typically hormone dependent and relies on androgen receptor signaling. Current therapies target the androgen receptor to halt the spread of the disease, but most patients become resistant to the treatment.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Sponsored by

Genomics is a key element in the potential of precision medicine to transform oncology. 

Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Sponsored by

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.